Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 155

Similar articles for PubMed (Select 20930934)

1.

Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma.

Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O, Sayed S, Leoncini L.

PLoS One. 2010 Sep 24;5(9). pii: e12960. doi: 10.1371/journal.pone.0012960.

2.

Functional interactions among members of the miR-17-92 cluster in lymphocyte development, differentiation and malignant transformation.

Lai M, Xiao C.

Int Immunopharmacol. 2015 Apr 11. pii: S1567-5769(15)00143-5. doi: 10.1016/j.intimp.2015.03.041. [Epub ahead of print]

PMID:
25870038
3.

CDKN1A and FANCD2 are potential oncotargets in Burkitt lymphoma and multiple myeloma.

Han SS, Tompkins VS, Son DJ, Han S, Yun H, Kamberos NL, Dehoedt CL, Gu C, Holman C, Tricot G, Zhan F, Janz S.

Exp Hematol Oncol. 2015 Mar 27;4:9. doi: 10.1186/s40164-015-0005-2. eCollection 2015.

4.

Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.

Robaina MC, Mazzoccoli L, Arruda VO, Reis FR, Apa AG, de Rezende LM, Klumb CE.

Exp Mol Pathol. 2015 Apr;98(2):200-7. doi: 10.1016/j.yexmp.2015.03.006. Epub 2015 Mar 4.

PMID:
25746661
5.

miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Zajdel M, Rymkiewicz G, Chechlinska M, Blachnio K, Pienkowska-Grela B, Grygalewicz B, Goryca K, Cieslikowska M, Bystydzienski Z, Swoboda P, Walewski J, Siwicki JK.

Tumour Biol. 2015 Feb 13. [Epub ahead of print]

PMID:
25677902
6.

Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma.

Iqbal J, Shen Y, Huang X, Liu Y, Wake L, Liu C, Deffenbacher K, Lachel CM, Wang C, Rohr J, Guo S, Smith LM, Wright G, Bhagavathi S, Dybkaer K, Fu K, Greiner TC, Vose JM, Jaffe E, Rimsza L, Rosenwald A, Ott G, Delabie J, Campo E, Braziel RM, Cook JR, Tubbs RR, Armitage JO, Weisenburger DD, Staudt LM, Gascoyne RD, McKeithan TW, Chan WC.

Blood. 2015 Feb 12;125(7):1137-45. doi: 10.1182/blood-2014-04-566778. Epub 2014 Dec 10.

PMID:
25498913
7.

A microRNA-mediated regulatory loop modulates NOTCH and MYC oncogenic signals in B- and T-cell malignancies.

Ortega M, Bhatnagar H, Lin AP, Wang L, Aster JC, Sill H, Aguiar RC.

Leukemia. 2015 Apr;29(4):968-76. doi: 10.1038/leu.2014.302. Epub 2014 Oct 14.

PMID:
25311243
8.

Oncogene addiction: resetting the safety switch?

Li Y, Choi PS, Felsher DW.

Oncotarget. 2014 Sep 30;5(18):7986-7. No abstract available.

9.

Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations.

La Starza R, Borga C, Barba G, Pierini V, Schwab C, Matteucci C, Lema Fernandez AG, Leszl A, Cazzaniga G, Chiaretti S, Basso G, Harrison CJ, Te Kronnie G, Mecucci C.

Blood. 2014 Dec 4;124(24):3577-82. doi: 10.1182/blood-2014-06-578856. Epub 2014 Sep 30.

PMID:
25270907
10.

Novel approach for coexpression analysis of E2F1-3 and MYC target genes in chronic myelogenous leukemia.

Wang F, Chan LW, Cho WC, Tang P, Yu J, Shyu CR, Tsui NB, Wong SC, Siu PM, Yip SP, Yung BY.

Biomed Res Int. 2014;2014:439840. doi: 10.1155/2014/439840. Epub 2014 Aug 10.

11.
12.

Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer.

Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, Qin YY, Gong W, Quan ZW.

Mol Cancer. 2014 Jun 23;13:156. doi: 10.1186/1476-4598-13-156.

13.

MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8185-90. doi: 10.1073/pnas.1322466111. Epub 2014 May 19.

14.

MicroRNAs as regulators and mediators of c-MYC function.

Jackstadt R, Hermeking H.

Biochim Biophys Acta. 2015 May;1849(5):544-553. doi: 10.1016/j.bbagrm.2014.04.003. Epub 2014 Apr 13. Review.

PMID:
24727092
15.

Burkitt lymphoma and MYC: what else is new?

Said J, Lones M, Yea S.

Adv Anat Pathol. 2014 May;21(3):160-5. doi: 10.1097/PAP.0b013e3182a92cde. Review.

PMID:
24713985
16.

[Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].

Zhou J, Xia C, Shen Q, Yin H, Zhang X, Shi Q, Zhou X, Ma J.

Zhonghua Bing Li Xue Za Zhi. 2014 Jan;43(1):8-14. Chinese.

PMID:
24713242
17.

The c-MYC protooncogene expression in cholesteatoma.

Palkó E, Póliska S, Csákányi Z, Katona G, Karosi T, Helfferich F, Penyige A, Sziklai I.

Biomed Res Int. 2014;2014:639896. doi: 10.1155/2014/639896. Epub 2014 Feb 10.

18.

Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.

Wang M, Yang W, Li M, Li Y.

Exp Mol Pathol. 2014 Apr;96(2):261-6. doi: 10.1016/j.yexmp.2014.02.015. Epub 2014 Mar 6.

PMID:
24613688
19.

A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Salaverria I, Martin-Guerrero I, Wagener R, Kreuz M, Kohler CW, Richter J, Pienkowska-Grela B, Adam P, Burkhardt B, Claviez A, Damm-Welk C, Drexler HG, Hummel M, Jaffe ES, Küppers R, Lefebvre C, Lisfeld J, Löffler M, Macleod RA, Nagel I, Oschlies I, Rosolowski M, Russell RB, Rymkiewicz G, Schindler D, Schlesner M, Scholtysik R, Schwaenen C, Spang R, Szczepanowski M, Trümper L, Vater I, Wessendorf S, Klapper W, Siebert R; Molecular Mechanisms in Malignant Lymphoma Network Project; Berlin-Frankfurt-Münster Non-Hodgkin Lymphoma Group.

Blood. 2014 Feb 20;123(8):1187-98. doi: 10.1182/blood-2013-06-507996. Epub 2014 Jan 7.

20.

c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies.

Tao J, Zhao X, Tao J.

Cell Cycle. 2014;13(2):191-8. doi: 10.4161/cc.27646. Epub 2014 Jan 6. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk